PER 3.70% 8.4¢ percheron therapeutics limited

Ann: ATL1102 tox study to support clinical program in the US, page-3

  1. 750 Posts.
    lightbulb Created with Sketch. 253
    seems like they've changed minds on not pushing forward in the US. Happy with this step forward, new CCO probably pushing this as a priority especially with discussions on potential US listing, need to at least have an opportunity for clinical trials and removing the hold is key! Onwards and upwards, combo study next.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.003(3.70%)
Mkt cap ! $75.73M
Open High Low Value Volume
8.1¢ 8.4¢ 8.1¢ $79.19K 960.1K

Buyers (Bids)

No. Vol. Price($)
1 100200 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 114242 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.